Skip To Content
BuzzFeed News Home Reporting To You

Utilizamos cookies, próprios e de terceiros, que o reconhecem e identificam como um usuário único, para garantir a melhor experiência de navegação, personalizar conteúdo e anúncios, e melhorar o desempenho do nosso site e serviços. Esses Cookies nos permitem coletar alguns dados pessoais sobre você, como sua ID exclusiva atribuída ao seu dispositivo, endereço de IP, tipo de dispositivo e navegador, conteúdos visualizados ou outras ações realizadas usando nossos serviços, país e idioma selecionados, entre outros. Para saber mais sobre nossa política de cookies, acesse link.

Caso não concorde com o uso cookies dessa forma, você deverá ajustar as configurações de seu navegador ou deixar de acessar o nosso site e serviços. Ao continuar com a navegação em nosso site, você aceita o uso de cookies.

Trump Just Named A Bush Administration Doctor To Head The FDA

The White House has named Scott Gottlieb to head the US agency charged with monitoring food and drug safety nationwide.

Last updated on March 10, 2017, at 9:13 p.m. ET

Posted on March 10, 2017, at 8:22 p.m. ET

American Enterprise Institute

The Trump administration Friday named former Bush administration official, Scott Gottlieb, to head the US Food and Drug Administration (FDA) in a long expected move.

A physician, Gottlieb served under the Bush administration as a deputy commissioner at FDA, where he dealt with scientific and regulatory affairs. He is expected to now lead efforts at the $4.9 billion agency to approve prescription drugs more quickly, under the recently approved 21st Century Cures Act.

Gottlieb has advocated for speedier approval for generic drugs, and argued that there is a need to modernize the way that the agency approaches promising but novel approaches to treatments, like gene therapies, and evaluates them for clinical use.

Gottlieb has also proposed that the agency's attention should be focused on risks to large parts of the population, such as food safety, over regulating relatively less risky areas such as phone apps.

"He will have an unusually broad perspective on the full healthcare delivery and finance system," law professor Erika Lietzan of the University of Missouri told BuzzFeed News. "I don’t fully agree with all of his views, but I think he is quite informed and thoughtful."

"One thing that’s particularly important to me is that he’s pro-vaccine — that is refreshing to me considering what we’ve been hearing in the last few weeks," Eric Topol, a professor at the Scripps Research Institute, told BuzzFeed News. He called Gottlieb "a very qualified candidate."

"I think he is a great choice," Kavita Patel, a non-resident fellow at the Brookings Institution, told BuzzFeed News. "He has always been somebody who’s put science and the best evidence ahead of everything else including politics."

"I expect his tenure to be marked by bold policy initiatives and strong leadership," Coleen Klasmeier, a law firm partner at the Sidley Austin LLP, told BuzzFeed News.

Gottlieb is a resident fellow at the American Enterprise Institute, a free enterprise focused think tank, and a partner at New Enterprise Associates.


This story has been updated with comments from Eric Topol.

A BuzzFeed News investigation, in partnership with the International Consortium of Investigative Journalists, based on thousands of documents the government didn't want you to see.